Table 2.
Subgroup analysis of the association between AGR and OS
| Subgroup factor | Divided standard | No. of studies | Pooled HR (95% CI) | P-value | Heterogeneity
|
|
|---|---|---|---|---|---|---|
| I2 (%) | Phet | |||||
|
| ||||||
| Cancer type | UTCC24,31 | 2 | 0.37 (0.18–0.56) | <0.001 | 14.5 | 0.279 |
| RCC23,33 | 2 | 0.63 (0.38–0.88) | <0.001 | 0.0 | 0.970 | |
| BC26,34 | 2 | 0.30 (0.16–0.44) | <0.001 | 55.9 | 0.132 | |
| Sample size | ≥30033,34 | 2 | 0.51 (0.35–0.67) | <0.001 | 36.8 | 0.208 |
| <30023,24,26,31 | 4 | 0.29 (0.16–0.42) | <0.001 | 0.0 | 0.445 | |
| Cutoff value | ≥1.4726,33,34 | 3 | 0.38 (0.26–0.50) | <0.001 | 72.6 | 0.026 |
| <1.4723,24,31 | 3 | 0.37 (0.18–0.56) | <0.001 | 0.0 | 0.551 | |
Abbreviations: BC, bladder carcinoma; RCC, renal cell carcinoma; UTCC, upper tract urothelial carcinoma.